2024-05-06 19:26:22
The American laboratory Pfizer announced yesterday a sharp drop in its first quarter results, which it had anticipated due to the decline in sales of its products against covid-19, in particular treatment and the vaccine.
The company’s sales fell 20%, to 14.88 billion dollars, and its net profit fell 44%, to 3 thousand 110 million dollars.
Las figures are much better than expected by the consensus of the analysts, who had forecast sales of 13,870 million dollars and a net profit of 2,902 million.
Precisely, with the profit per share excluding exceptional items, a reference for the markets, Pfizer surprised by announcing 82 cents, when the consensus had predicted 51 cents.
The medical laboratory took the opportunity to revise upwards its forecast for the entire year with the results: where it projects between 2.15 and 2.35 dollars per share (in comparable terms), compared to the previous 2.05 to 2.25 dollars per share. past record.
Related
2024-05-06 19:26:22